The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 3, Pages e60038
Publisher
Public Library of Science (PLoS)
Online
2013-03-22
DOI
10.1371/journal.pone.0060038
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Labeling of Oxidizable Proteins with a Photoactivatable Analog of the Antitumor Agent DMXAA: Evidence for Redox Signaling in Its Mode of Action
- (2015) Romy Brauer et al. NEOPLASIA
- Macrophage Proinflammatory Response to Francisella tularensis Live Vaccine Strain Requires Coordination of Multiple Signaling Pathways
- (2014) L. E. Cole et al. JOURNAL OF IMMUNOLOGY
- Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation
- (2011) Jing Sun et al. BIOCHEMICAL PHARMACOLOGY
- Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer
- (2011) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- STING is a direct innate immune sensor of cyclic di-GMP
- (2011) Dara L. Burdette et al. NATURE
- DNA released from dying host cells mediates aluminum adjuvant activity
- (2011) Thomas Marichal et al. NATURE MEDICINE
- Pharmacologic Activation of the Innate Immune System to Prevent Respiratory Viral Infections
- (2010) Guanjun Cheng et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Immunogenicity of Whole-Parasite Vaccines against Plasmodium falciparum Involves Malarial Hemozoin and Host TLR9
- (2010) Cevayir Coban et al. Cell Host & Microbe
- The Ubiquitin Ligase TRIM56 Regulates Innate Immune Responses to Intracellular Double-Stranded DNA
- (2010) Tetsuo Tsuchida et al. IMMUNITY
- Activation of the Nucleotide Oligomerization Domain Signaling Pathway by the Non-bacterially Derived Xanthone Drug 5′6-Dimethylxanthenone-4-acetic Acid (Vadimezan)
- (2010) Guanjun Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-β-mediated antiviral activity in vitro and in vivo
- (2010) Kari Ann Shirey et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Plasmacytoid Dendritic Cells Delineate Immunogenicity of Influenza Vaccine Subtypes
- (2010) S. Koyama et al. Science Translational Medicine
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
- (2009) Hiroki Ishikawa et al. NATURE
- Molecular basis of improved immunogenicity in DNA vaccination mediated by a mannan based carrier
- (2008) Choon Kit Tang et al. BIOMATERIALS
- Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer
- (2008) M J McKeage et al. BRITISH JOURNAL OF CANCER
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More